Skip to main content
. 2022 Aug 3;70(1):18. doi: 10.1007/s00005-022-00657-6

Table 2.

In-hospital management and major outcomes

COVID-19 Patients (n = 109)
 Main drug therapies, n
 Glucocorticoids 33
 Hydroxychloroquine 8
 Azithromycin 17
 Lopinavir/ritonavir 66
 Interleukin-6 or Jak-STAT inhibitors 26
 Heparins 95
Main clinical outcomes, n
 Vascular thrombosis (any) 25
 Pulmonary thromboembolism 3
 Stroke 1
 Myocardial infarction 4
 Severe bleeding 14
 Invasive mechanical ventilation 61
 Death 38
 Days of hospital stay, median (interquartile range) 14 (11–25)